C71T
CANCELLED SECTION 71
07/17/2026
Back to search
Official data from USPTO
INZEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
08/11/2026
Trademark type
Combined
Nice classes
5
Filing date
11/23/2018
Registration date
12/31/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/17/2026
Last transaction
08/11/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
MINHANG DISTRICT, SHANGHAI, CN
Examiner
CIANCI, RYAN MICHAEL
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "INZEX". "INZE" is dark blue. The tail of the "E" is light blue and forms half of the letter "X". The other half of the "X" is light green and dark green. To the right of "INZEX", a series of dark blue and light blue ovals emit from a single dark green oval. The gray background is not claimed as a feature of the mark.
Holders and representatives
Holders
SHANGHAI YUN ZE BIOLOGICAL TECHNOLOGY CO., LTD.
Representatives
JOE MCKINNEY MUNCY MUNCY, GEISSLER, OLDS & LOWE, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Dressingsmedical; Medical diagnostic reagents; Diagnostic radiopharmaceutical agent for use in PET imaging; blood for medical purposes; Diagnostic radiopharmaceutical preparations; Diagnostic agentspreparations and substances for medical purposes; biological tissue cultures for medical purposes; diagnostic biomarker reagents for medical purposes; Medical diagnostic reagents and assays for testing of body fluids; diagnostic preparations for medical purposes
Publications
History of USPTO decisions and trademark events.
31 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
12/31/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/25/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/19/2020
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
04/15/2020
XXCR
GENERIC MADRID TRANSACTION CREATED
04/15/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/31/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
12/31/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/15/2019
PUBO
PUBLISHED FOR OPPOSITION
10/15/2019
GPNX
NOTIFICATION PROCESSED BY IB
10/12/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/25/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/25/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/25/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/07/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/24/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/24/2019
ALIE
ASSIGNED TO LIE
08/24/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/16/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/16/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/13/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/13/2019
RFNT
REFUSAL PROCESSED BY IB
03/29/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/13/2019
RFRR
REFUSAL PROCESSED BY MPU
03/13/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/02/2019
CNRT
NON-FINAL ACTION WRITTEN
03/01/2019
DOCK
ASSIGNED TO EXAMINER
02/25/2019
MAFR
APPLICATION FILING RECEIPT MAILED
02/12/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/06/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/31/2019
Continuous trademark protection
Get notified about every new filing that threatens INZEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.